Overactive bladder. Strategies for better recognition and management.
Smith
Diane A
DA
Urohealthcare, Newtown Square, Pa., USA.
D001521:Behavior Therapy; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D003408:Cresols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004599:Electric Stimulation Therapy; D005081:Exercise Therapy; D006801:Humans; D015994:Incidence; D008333:Mandelic Acids / Q000627:therapeutic use; D008487:Medical History Taking; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009722:Nurse Practitioners; D024802:Nurse's Role; D009730:Nursing Assessment; D017773:Pelvic Floor; D010665:Phenylpropanolamine; D010808:Physical Examination; D015995:Prevalence; D011320:Primary Health Care; D012017:Referral and Consultation; D014039:Toilet Training; D000068737:Tolterodine Tartrate; D014481:United States / Q000453:epidemiology; D014555:Urination Disorders / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014563:Urodynamics
D001559:Benzhydryl Compounds; D003408:Cresols; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin